Lawrence Kolaczkowski

USPTO Granted Patents = 18 (Patent Applications = 1)

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 55(Granted Patents)

Location History:

Vernon Hills, IL (US) (1988 - 1991)
Gurnee, IL (US) (1992 - 2017)

Company Filing History:

13 out of 4,177

Abbott Laboratories Corporation

4. 1 out of 832,680

Other

patents

Years Active: 1988-2017

Loading Chart...

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9580410 - 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1 (2017-02-28),

2. 8835647 - 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1 (2014-09-16),

3. 8399468 - Octahydro-pyrrolo[3,4-B]pyrrole derivatives (2013-03-19),

4. 8372987 - 2-{(R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1 (2013-02-12),

5. 7968707 - Retroviral protease inhibiting compounds (2011-06-28),

6. 7728031 - Octahydro-pyrrolo[3,4-b]pyrrole derivatives (2010-06-01),

7. 7491718 - Sulfonamides having antiangiogenic and anticancer activity (2009-02-17),

8. 7279582 - Retroviral protease inhibiting compounds (2007-10-09),

9. 7074932 - Preparation of quinoline-substituted carbonate and carbamate derivatives (2006-07-11),

10. 6579986 - Preparation of quinoline-substituted carbonate and carbamate derivatives (2003-06-17),

11. 6472529 - Retroviral protease inhibiting compounds (2002-10-29),

12. 6417366 - Preparation of quinoline-substituted carbonate and carbamate derivatives (2002-07-09),

13. 6313296 - Retroviral protease inhibiting compounds (2001-11-06),

14. 6184376 - Synthesis of acyclic nucleoside derivatives (2001-02-06),

15. 5319105 - Derivatives and anologs of monoethylglycinexylidide (1994-06-07),

Title: **Lawrence Kolaczkowski: A Profile of Innovation**

Introduction

Lawrence Kolaczkowski, based in Gurnee, IL, is a prominent inventor with a significant contribution to the field of pharmaceuticals. With a total of 18 patents to his name, he has demonstrated a consistent ability to innovate and advance medical treatments through his research and discoveries.

Latest Patents

Among his latest patents, Lawrence has notably developed the 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1. This invention includes various methods of producing the crystalline form, compositions containing it, and treatment methods for patients suffering from various diseases using this compound. His work showcases the depth of his expertise in medicinal chemistry and its applications.

Career Highlights

Throughout his career, Lawrence has been associated with notable companies such as Abbott Laboratories Corporation and AbbVie Inc., where he contributed to various innovative projects. His experience in these leading pharmaceutical organizations has undoubtedly shaped his capabilities as an inventor and researcher.

Collaborations

Lawrence has collaborated with esteemed professionals in his field, including Stephen L. Condon and Eric J. Stoner. These partnerships have enriched his inventions and helped foster an environment of creativity and innovation as they worked together on advancing medical science.

Conclusion

Lawrence Kolaczkowski stands out as a dedicated inventor, contributing significantly to the world of pharmaceuticals through his patents and collaborative efforts. His work continues to impact the industry, propelling forward advancements in the treatment and management of diseases.

This text is generated by artificial intelligence and may not be accurate.